12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

GlaxoSmithKline preclinical data

Researchers from the Juntendo University School of Medicine showed that systemic and local injections of Avandia rosiglitazone reduced the development of tactile allodynia and decreased inflammation in the area of nerve injury in...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >